4-Year-Old Boy: Speech Delay + Behavioural Difficulties

Normal Language Milestones (for context)

• Kaplan & Sadock's Comprehensive Textbook of Psychiatry

Differential Diagnosis

1. Autism Spectrum Disorder (ASD) - TOP PRIORITY

• Impaired emotional reciprocity / social interaction
• Reduced or absent nonverbal communication (eye contact, gestures, facial expression)
• Difficulty forming and maintaining relationships

• Stereotyped motor movements
• Rigid adherence to routines/rituals
• Restricted, fixed interests
• Hyper- or hyporeactivity to sensory input

• ~1/3 of ASD children have co-occurring intellectual disability
• Up to 25% show language regression (words present then lost)
• "Theory of mind" deficit: difficulty inferring others' feelings leads to social awkwardness
• Exploratory play is restricted; toys used in ritualistic, idiosyncratic ways
• Symptoms begin in the early developmental period but may not be clearly recognized until school age in milder cases
• Kaplan and Sadock's Synopsis of Psychiatry

2. Isolated / Benign Developmental Speech Delay

• A subset of otherwise neurologically normal children who are "late talkers"
• 3:1 male predominance, often positive family history
• Comprehension and general intelligence are normal - this is the key differentiator
• Communication by gestures is facile
• When speech eventually develops, it may progress rapidly
• However, many such children later have dyslexia/dysgraphia, so follow-up is essential
• (Notably, Albert Einstein reportedly did not speak until age 4)
• Adams and Victor's Principles of Neurology

3. Hearing Loss / Congenital Deafness - MUST EXCLUDE FIRST

• Estimated 3 million American children have hearing defects; 0.1% of school-age children are deaf
• Risk factors: familial deaf mutism, congenital rubella, erythroblastosis fetalis, chronic bilateral ear infections (very common), meningitis history, ototoxic drug exposure
• The deaf child typically: appears eager to communicate via gesture/facial expression, has normal social milestones, has normal intelligence (Leiter scale)
• Babbling is normal up to 6 months then becomes stereotyped and restricted
• Audiometry (and BAER if needed) is mandatory in any child with speech delay
• Adams and Victor's Principles of Neurology

4. Global Developmental Delay / Intellectual Disability

• 35-50% of children with pathological speech delay have global developmental delay or cerebral palsy
• Developmental milestones across multiple domains (motor, cognitive, social) are all delayed
• Unlike isolated speech delay, general intelligence is also impaired

5. Specific Language Impairment (SLI) / Communication Disorder

• Selective delay in language acquisition with relatively preserved nonverbal intelligence
• No social communication deficits (distinguishes from ASD)
• No hearing loss

6. Other considerations:

• ADHD (behavioural difficulties, impaired attention affecting language acquisition)
• Selective mutism (speaks in some settings but not others)
• Childhood disintegrative disorder (normal development x2 years, then regression)
• Fragile X syndrome (most common inherited intellectual disability; characteristic physical features)
• Landau-Kleffner syndrome (acquired epileptic aphasia with bitemporal EEG discharges)
• Lead toxicity, hypothyroidism, iron deficiency (metabolic/toxic causes)

History - Key Questions

• Age of first words? First sentences?
• Regression? (Loss of words previously acquired - red flag for ASD)
• Motor milestones (walking, fine motor)?
• Bladder/bowel control?

• Does he attempt to communicate? How (words, gestures, pointing)?
• Does he understand commands? (receptive vs expressive language)
• Is speech intelligible? Echolalia present?

• Specific behavioural difficulties (tantrums, aggression, rigidity, inattention)?
• Response to name when called?
• Eye contact?
• Repetitive movements (hand flapping, rocking)?
• Restricted interests? Insistence on sameness/routines?
• Play: imaginative/symbolic play present?
• Social interest in peers and adults?

• Passes hearing at birth (newborn screen)?
• Parents' concern about hearing? Turns to sounds?
• Recurrent ear infections/glue ear?

• Perinatal complications, prematurity?
• Seizures?
• Family history of ASD, speech delay, intellectual disability, learning disorders?
• Consanguinity?

Examination

• Eye contact, joint attention (pointing to share interest)
• Response to name
• Play quality (functional vs repetitive)
• Social reciprocity with parent and examiner

Investigations

Management

Immediate referrals (do not wait for diagnosis to refer):

1. Audiology - hearing assessment urgently
2. Speech and Language Therapy (SLT) - both diagnostic and therapeutic
3. Developmental Paediatrics / Child Psychiatry - formal ASD/developmental evaluation
4. Early intervention programme - services available without waiting for a formal diagnosis in most health systems

If ASD confirmed:

• Applied Behaviour Analysis (ABA) - structured operant conditioning; evidence for improving adaptive behaviours
• Early Start Denver Model (ESDM) - for very young children; naturalistic settings (home, daycare); parents as co-therapists; integrates ABA with play
• Pivotal Response Training (PRT) - parent-delivered; targets gateway social behaviours
• Social Skills Training - group-based; teaches initiation, greetings, emotion recognition
• Cognitive-Behavioural Therapy (CBT) - for co-morbid anxiety, OCD, repetitive behaviours

• Risperidone or aripiprazole: for significant irritability, aggression, self-injurious behaviour
• Melatonin: for insomnia (very prevalent in ASD)
• Stimulants/atomoxetine: for co-morbid ADHD symptoms

• Parent training (Hanen "More Than Words" programme)
• Carer psychological support
• Educational placement in specialist or supported mainstream setting

If isolated speech delay:

• SLT (direct and/or parent-mediated)
• Monitor for learning difficulties (dyslexia, dysgraphia) at school age
• Hearing aids if any hearing deficit

If hearing loss:

• ENT referral (grommets if otitis media with effusion)
• Hearing aid fitting
• Specialist hearing/speech education programme

Red Flags Warranting Urgent Assessment

• No babbling by 12 months
• No single words by 16 months
• No two-word phrases by 24 months
• Any loss of previously acquired language or social skills at any age
• No response to name
• Absence of joint attention (pointing, showing)
• Regression of any developmental skill

• Kaplan and Sadock's Synopsis of Psychiatry (Section 2.3 - Autism Spectrum Disorder; Communication Disorders)
• Kaplan & Sadock's Comprehensive Textbook of Psychiatry (Language Development)
• Adams and Victor's Principles of Neurology, 12th Edition (Developmental Speech Delay; Congenital Deafness)

Updated Assessment: Macrocephaly + Recurrent Respiratory Infections Narrows the Diagnosis Significantly

The Pathophysiology

• Goldman-Cecil Medicine

Differential Diagnosis: The MPS Spectrum

• Adams and Victor's Principles of Neurology; Cummings Otolaryngology; Emery's Elements of Medical Genetics

The Two Leading Diagnoses in This Boy

1. Hunter Syndrome (MPS II) - MOST LIKELY

• Recurrent infections - upper respiratory, otitis media (due to GAG accumulation in upper airway mucosa and eustachian tube dysfunction)
• Increasing head circumference (macrocephaly from cranial vault expansion + communicating hydrocephalus)
• Hearing loss - mixed conductive and sensorineural
• Coarsening of facial features (full lips, broad nose, wide-set eyes, large tongue)
• Hepatosplenomegaly
• Joint stiffness (claw hand, limited range of motion)
• Short stature / poor growth
• Speech delay + behavioural difficulties (hyperactivity, aggression)
• Progressive mental deterioration in severe form

• No corneal clouding (key differentiating feature)
• Slightly milder course
• Survival to adulthood possible in attenuated form

Hunter syndrome papules - firm cobblestone/reticular lesions (Andrews' Diseases of the Skin)

• Severe (neuronopathic): Progressive cognitive decline, death mid-teens
• Attenuated: Relatively preserved intelligence, survival into middle age
• Adams and Victor's Principles of Neurology; Emery's Elements of Medical Genetics

2. Sanfilippo Syndrome (MPS III) - IMPORTANT DIFFERENTIAL

• Most common MPS overall
• Presents age 2-3 years with progressive intellectual deterioration
• Behavioural problems are prominent and often severe (hyperactivity, aggression, sleep disturbance - sometimes the presenting complaint)
• Somatic features are milder - subtle coarsening, mild hepatosplenomegaly; no corneal clouding
• Heparan sulfate excreted in urine
• 4 subtypes (A, B, C, D) by enzyme defect - all phenotypically similar
• Progressive deterioration into vegetative state, death in third decade
• No effective enzyme replacement therapy currently available

3. Hurler Syndrome (MPS I) - Less likely given male sex and absence of corneal clouding yet

• Autosomal recessive - affects both sexes
• Most severe MPS; begins in first year of life
• Corneal clouding is characteristic (differentiates from Hunter)
• Gargoyle facies, macrocephaly, kyphosis, broad stubby hands
• Conductive deafness, corticospinal signs
• Hepatosplenomegaly, valvular heart disease
• Death first decade

Additional Features to Elicit Now

• Family history of affected males (maternal uncles/cousins) - strongly suggests Hunter (X-linked)
• Age of symptom onset and progression (is it worsening?)
• Snoring, obstructive sleep apnoea (from upper airway GAG deposition)
• Diarrhoea (common in Hunter)
• Joint stiffness, difficulty walking
• Skin changes (pebbly papules)

• Head circumference - plot on centile chart, confirm progressive macrocephaly
• Facial features: coarsening (flat nasal bridge, full lips, prominent brow, large tongue)
• Corneas: slit-lamp examination - clouding = Hurler; clear = Hunter
• Hepatosplenomegaly - palpate abdomen
• Joints: range of motion, claw hand, genu valgum
• Cardiovascular: heart murmur (valvular disease)
• Spine: kyphosis/gibbus deformity
• Hearing: examine ears, formal audiology
• Skin: look for pebbly papules (Hunter)
• Airway: tonsillar/adenoidal hypertrophy

Investigations

Management

Disease-Modifying Therapy

• Hunter (MPS II): Idursulfase (Elaprase) - weekly IV infusion; may delay somatic features, but limited CNS penetration (does not cross blood-brain barrier effectively)
• Hurler (MPS I): Laronidase (Aldurazyme) - recombinant α-L-iduronidase
• ERT is available for MPS I, II, IVA, VI, VII
• Critical: must start before significant neurological decline for maximum benefit
• Neither ERT nor bone marrow transplantation has been shown effective in Sanfilippo (MPS III)

• Hurler (MPS I): HSCT (cord blood from unrelated donors) is the treatment of choice when performed early (before age 2-2.5 years, before significant CNS decline)
• Less effective for Hunter or Sanfilippo
• Does not improve eye or bone disease in Hurler

• Experimental; promising for MPS I and MPS VI
• Several clinical trials ongoing
• Goldman-Cecil Medicine; Adams and Victor's Principles of Neurology

Supportive/Symptomatic Management

Anaesthetic alert: All MPS patients are high anaesthetic risk due to difficult airway (macroglossia, short neck, tracheal narrowing), atlantoaxial instability, and cardiac involvement. This must be flagged prominently in the medical record.

Summary: The Diagnostic Hierarchy in This Boy

4-year-old boy
├── Speech delay + behavioural difficulties
├── PROGRESSIVE MACROCEPHALY  →  Storage / infiltrative / CSF disorder
└── RECURRENT RESPIRATORY INFECTIONS  →  Airway GAG deposition

Combined pattern → MUCOPOLYSACCHARIDOSIS

Male sex + X-linked pattern → HUNTER SYNDROME (MPS II) most likely
  Confirm with: Urine GAGs → Leukocyte iduronate-2-sulfatase → IDS gene analysis

If corneal clouding present → Hurler (MPS I)
If somatic features minimal, behaviour dominates → Sanfilippo (MPS III)

• Adams and Victor's Principles of Neurology, 12th ed. (MPS II/III sections)
• Goldman-Cecil Medicine (Mucopolysaccharidoses, Lysosomal Storage Disorders)
• Emery's Elements of Medical Genetics and Genomics (Hunter, Hurler, Sanfilippo)
• Cummings Otolaryngology Head and Neck Surgery (MPS - otologic manifestations)
• Andrews' Diseases of the Skin (Hunter syndrome skin findings)

Diagnosis: Fragile X Syndrome (FXS)

Genetics and Molecular Basis

The FMR1 Gene

• Locus: Xq27.3
• Gene: FMR1 (Fragile X Messenger Ribonucleoprotein 1)
• Mutation type: CGG trinucleotide repeat expansion in the 5' untranslated region
• Inheritance: X-linked (with unusual features - see below)

CGG Repeat Thresholds

• Robbins, Cotran & Kumar Pathologic Basis of Disease; Emery's Elements of Medical Genetics

How the Full Mutation Causes Disease

• Most abundant in brain and testes (explaining the two organs most affected)
• A cytoplasmic RNA-binding protein that transports mRNAs to neuronal dendrites
• A translation regulator at synapses - it suppresses protein synthesis via group I metabotropic glutamate receptor (mGluR) signalling
• Essential for synaptic plasticity - the molecular basis of learning and memory

FMRP action in neurons - loss of this protein in FXS disrupts synaptic plasticity (Robbins & Kumar)

The Unusual Inheritance Pattern

1. Anticipation

2. The Grandfather's Role (Premutation = FXTAS)

• The maternal grandfather has 55-200 CGG repeats (premutation)
• His premutation was passed to his daughter (the mother) unchanged - she is a carrier with premutation
• During the mother's oogenesis, the premutation expanded dramatically to a full mutation (>200 repeats)
• Her son inherited the full mutation → Fragile X Syndrome
• The grandfather himself never had FXS but developed FXTAS (toxic gain-of-function of the abnormal FMR1 mRNA - see below)

3. Normal Transmitting Males

4. Penetrance in Females

• 30-50% of females who inherit the full mutation have intellectual disability (compared with nearly 100% of males) - due to X-inactivation of the unaffected X in some cells providing partial protection

The Three FMR1-Associated Disorders

CGG Repeat Size    Person         Disorder
────────────────────────────────────────────────────────
>200 (full)        Males          FRAGILE X SYNDROME (FXS) - loss of FMRP
>200 (full)        Females        Mild-moderate ID in ~40-50%
55-200 (pre)       Males >50 yrs  FXTAS - toxic gain-of-function
55-200 (pre)       Females        FXPOI (Primary Ovarian Insufficiency) ~20%

FXTAS - Explaining the Grandfather

• Affects ~50% of male premutation carriers; onset after age 50 (peaks in 60s-70s)
• Mechanism: Toxic gain-of-function - the expanded FMR1 mRNA is NOT silenced (unlike full mutation) but is over-transcribed; the abnormal CGG-containing mRNA sequesters RNA-binding proteins into intranuclear inclusions in neurons - toxic neurodegeneration
• Clinical features:
  • Intention/kinetic tremor (this grandfather's presenting complaint)
  • Gait ataxia / balance problems (this grandfather's second complaint)
  • Executive cognitive dysfunction
  • Parkinsonism
  • Peripheral neuropathy
  • Dysautonomia, erectile dysfunction
  • Bilateral cerebellar/white matter hyperintensities on T2 MRI
• Bradley and Daroff's Neurology; Robbins & Kumar

FXPOI - The Mother's Risk

• 20% risk of Fragile X-associated Primary Ovarian Insufficiency (FXPOI) - premature ovarian failure before age 40 (vs ~1% in general population)
• Elevated FSH, decreased anti-Müllerian hormone, early menopause (~5 years earlier than average)
• This should be discussed with the mother as part of genetic counselling

Full Clinical Features of FXS in This Boy

Facial Dysmorphism (classic triad confirmed on exam):

• Long narrow face
• Prominent ears (large, may be low-set)
• Prominent jaw (prognathism)
• Also: high forehead, slightly large head

Post-pubertal feature (to watch for):

• Macroorchidism (large testes) - most reliable physical sign in adult males; due to FMRP deficiency in testicular tissue

Connective tissue features:

• Hyperextensible joints
• Skin striae
• Mitral valve prolapse

Neurodevelopmental profile:

• Intellectual disability - moderate to severe in males (IQ typically 40-70)
• Speech delay - halting, repetitive, perseverative speech quality
• Autism spectrum features - 50-75% of FXS males; eye gaze avoidance, poor social reciprocity
• ADHD/hyperactivity - very common (90% show behavioural difficulties)
• Anxiety - prominent, especially social anxiety
• Sensory hypersensitivity - tactile, auditory
• Epilepsy - ~30% of cases
• Emery's Elements of Medical Genetics; Robbins & Kumar

Investigations

Management

Neurodevelopmental

Pharmacological (symptom-targeted)

Investigational / Targeted Therapies

• mGluR5 antagonists (e.g. mavoglurant, arbaclofen): Rationale from the mGluR theory - blocking excessive glutamate signalling should restore synaptic balance. Trials have been disappointing in adults but ongoing in children
• GABA-B agonists (arbaclofen): Addresses GABA-glutamate imbalance in FXS
• Gene therapy / CRISPR: Preclinical research to restore FMRP expression

For the Family

• Genetic counselling: All family members at risk should be offered FMR1 testing
  • The mother (likely premutation carrier - confirm with testing)
  • Maternal aunts (may carry premutation - ovarian insufficiency risk)
  • Maternal grandfather (premutation confirmed by FXTAS)
• Pre-implantation genetic diagnosis (PGD) / prenatal diagnosis available for future pregnancies
• FXTAS counselling for grandfather - refer to neurology; no disease-modifying treatment but supportive care (propranolol for tremor, physiotherapy for balance)
• FXPOI counselling for mother - endocrine monitoring, fertility planning, HRT consideration

The Pedigree in This Case - Explained

GENERATION I:
  Grandfather ─────── Grandmother
  (premutation: FXTAS   (normal)
  tremor + ataxia, 60s)
         │
  ┌──────┴──────┐
  │             │
GENERATION II:
Mother (carrier     Uncle (affected: learning
premutation → full   difficulties - inherited
mutation during her  premutation from grandfather,
oogenesis)          not fully expanded as
                    transmitted paternally*)
         │
GENERATION III:
THIS BOY (full mutation, FXS)

Key Concepts Summary

• Robbins, Cotran & Kumar Pathologic Basis of Disease (FXS molecular mechanisms)
• Thompson & Thompson Genetics and Genomics in Medicine, 9th ed.
• Emery's Elements of Medical Genetics and Genomics (clinical features, FXTAS)
• Bradley and Daroff's Neurology in Clinical Practice (FXTAS)
• Henry's Clinical Diagnosis and Management by Laboratory Methods (laboratory diagnosis)